Abstract
This chapter explores the clinical use of botulinum toxin therapy in ophthalmology and ophthalmic surgery. Ophthalmic conditions that can benefit from botulinum toxin therapy include blepharospasm, strabismus, nystagmus, lacrimal hypersecretion syndromes, eyelid retraction and spastic entropion among others. Since its first use in blepharospasm in 1983, toxin therapy has become the treatment of choice for blepharospasm with successful outcomes. This chapter also explores the techniques of injection, application and complications of toxin therapy in these conditions. Whilst generally considered safe, some of the complications of ophthalmic toxin therapy include ptosis, diplopia, dry eyes and epiphora.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology. 1980;87(10):1044–9. https://doi.org/10.1016/s0161-6420(80)35127-0.
Taylor JD, Kraft SP, Kazdan MS, Flanders M, Cadera W, Orton RB. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study. Can J Ophthalmol. 1991;26(3):133–8. http://www.ncbi.nlm.nih.gov/pubmed/2054723. Accessed December 1, 2019
Scott AB, Stubbs HA, Kennedy RA. Botulinum a toxin injection as a treatment for blepharospasm. Arch Ophthalmol. 1985;103(3):347–50. https://doi.org/10.1001/archopht.1985.01050030043017.
Tsoy EA, Buckley EG, Dutton JJ. Treatment of Blepharospasm with botulinum toxin. Am J Ophthalmol. 1985;99(2):176–9. https://doi.org/10.1016/0002-9394(85)90228-4.
Dutton JJ, Buckley EG. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology. 1988;95(11):1529–34. https://doi.org/10.1016/s0161-6420(88)32977-5.
Calace P, Cortese G, Piscopo R, et al. Treatment of Blepharospasm with botulinum neurotoxin type A: long-term results. Eur J Ophthalmol. 2003;13(4):331–6. https://doi.org/10.1177/112067210301300401.
Osako M, Keltner JL. Botulinum A toxin (Oculinum) in ophthalmology. Surv Ophthalmol. 1991;36(1):28–46. https://doi.org/10.1016/0039-6257(91)90207-v.
Kraft SP, Lang AE. Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations. Can J Neurol Sci. 1988;15(3):276–80. https://doi.org/10.1017/s0317167100027748.
Mauriello JA Jr. Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin. Neurology. 1985;35(0028-3878 (Print)):1499–500.
Jitpimolmard S, Tiamkao S, Laopaiboon M. Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases. J Neurol Neurosurg Psychiatry. 1998;64(6):751–7. https://doi.org/10.1136/jnnp.64.6.751.
Grandas F, Elston J, Quinn N, Marsden CD. Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry. 1988;51(6):767–72. https://doi.org/10.1136/jnnp.51.6.767.
Cillino S, Raimondi G, Guépratte N, et al. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes. Eye. 2010;24(4):600–7. https://doi.org/10.1038/eye.2009.192.
Elston JS. Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections. Br J Ophthalmol. 1987;71(9):664–8. https://doi.org/10.1136/bjo.71.9.664.
Grandas F, Elston J, Quinn JN, Marsden CD, Quinn N. Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry. 1988;51:767–72. https://doi.org/10.1136/jnnp.51.6.767.
Engstrom PF, Arnoult JB, Mazow ML, et al. Effectiveness of botulinum toxin therapy for essential Blepharospasm. Ophthalmology. 1987;94(8):971–5. https://doi.org/10.1016/S0161-6420(87)33338-X.
Frueh BR, Musch DC. Treatment of facial spasm with botulinum toxin. An interim report. Ophthalmology. 1986;93(7):917–23. https://doi.org/10.1016/s0161-6420(86)33641-8.
Dutton JJ. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects. Surv Ophthalmol. 1996;41(1):51–65. https://doi.org/10.1016/s0039-6257(97)81995-9.
Dutton JJ, Fowler AM. Botulinum toxin in ophthalmology. Surv Ophthalmol. 2007;52(1):13–31. https://doi.org/10.1016/j.survophthal.2006.10.003.
Carruthers J, Stubbs HA. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion. Can J Neurol Sci. 1987;14(1):42–5. https://doi.org/10.1017/s0317167100026159.
Owens PL, Strominger MB, Rubin PA, Veronneau-Troutman S. Large-angle exotropia corrected by intraoperative botulinum toxin a and monocular recession resection surgery. J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus. 1998;2(3):144–6. https://doi.org/10.1016/s1091-8531(98)90004-0.
Khan AO. Two horizontal rectus eye muscle surgery combined with botulinum toxin for the treatment of very large angle esotropia. A pilot study. Binocul Vis Strabismus Q. 2005;20(1):15–20. http://www.ncbi.nlm.nih.gov/pubmed/15828866. Accessed December 4, 2019
Jain S, Anand SS, Jones A. Intraoperative botulinum toxin in large angle strabismus. J Am Assoc Pediatr Ophthalmol Strabismus. 2015;19(4):e12. https://doi.org/10.1016/j.jaapos.2015.07.007.
McNeer KW, Tucker MG, Guerry CH, Spencer RF. Incidence of stereopsis after treatment of infantile esotropia with botulinum toxin A. J Pediatr Ophthalmol Strabismus. 2003;40(5):288–92. http://www.ncbi.nlm.nih.gov/pubmed/14560837. Accessed December 4, 2019
de Oliveira FC, de Oliveira GC, Cariello AJ, Felberg S, Osaki MH. Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia. Arq Bras Oftalmol. 2010;73(5):405–8. https://doi.org/10.1590/s0004-27492010000500003.
Sahlin S, Chen E, Kaugesaar T, Almqvist H, Kjellberg K, Lennerstrand G. Effect of eyelid botulinum toxin injection on lacrimal drainage. Am J Ophthalmol. 2000;129(4):481–6. https://doi.org/10.1016/s0002-9394(99)00408-0.
Carruthers J. The treatment of congenital nystagmus with Botox. J Pediatr Ophthalmol Strabismus. 1995;32(5):306–8. https://doi.org/10.3928/0191-3913-19950901-09.
Leigh RJ, Tomsak RL, Grant MP, et al. Effectiveness of botulinum toxin administered to abolish acquired nystagmus. Ann Neurol. 1992;32(5):633–42. https://doi.org/10.1002/ana.410320506.
Repka MX, Savino PJ, Reinecke RD. Treatment of acquired nystagmus with botulinum neurotoxin A. Arch Ophthalmol. 1994;112(10):1320–4. https://doi.org/10.1001/archopht.1994.01090220070025.
Corridan P, Nightingale S, Mashoudi N, Williams AC. Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm. Br J Ophthalmol. 1990;74(5):309–10. https://doi.org/10.1136/bjo.74.5.309.
Zheng L, Azar D. Angle-closure glaucoma following periorbital botulinum toxin injection. Clin Exp Ophthalmol. 2014;42(7):690–3. https://doi.org/10.1111/ceo.12293.
Liu M, Lee HC, Hertle RW, Ho AC. Retinal detachment from inadvertent intraocular injection of botulinum toxin A. Am J Ophthalmol. 2004;137(1):201–2. https://doi.org/10.1016/s0002-9394(03)00837-7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jafari, K., Jain, S. (2020). Botulinum Toxin Treatment in Ophthalmology and Ophthalmic Surgery. In: Jabbari, B. (eds) Botulinum Toxin Treatment in Surgery, Dentistry, and Veterinary Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-50691-9_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-50691-9_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-50690-2
Online ISBN: 978-3-030-50691-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)